Keros Therapeutics Inc
KROS
$10.66-3.96%
End of day · as of Oct 17, 2026, 8:00 AM ET
Mkt cap
$208.80M
EV/Sales
-0.32
P/E ratio
N/A
FY2025 Revenue
$243.86M
EPS (TTM)
$-3.22
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
35.68%
Beta
0.95
Div yield
N/A
Sector
Healthcare
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Latest reported KROS revenue for 2025-12-31 was $243.9M. Net income was $87.0M. KROS currently screens at market cap $208.8M.
Use this KROS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KROS income, balance, and cash tables.
Keros Therapeutics Inc (KROS) is a biotechnology company in the Healthcare sector.
Latest cached Keros Therapeutics Inc (KROS) revenue for Dec 31, 2025 was $243.9M. Net income was $87.0M. Statements: https://lician.com/financials/kros
Keros Therapeutics Inc (KROS) market capitalization is $208.8M on the latest cached snapshot.
Keros Therapeutics Inc (KROS) cached previous close $11.10; day range $10.66 – $11.11; volume 169,632. Session quote: https://lician.com/quote/kros
Keros Therapeutics Inc (KROS) latest cached earnings event is "KROS earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached KROS filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/kros